Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets

Cipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and young children.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news